Clinical features of hepatic veno-occlusive disease induced by gynura root: analysis of 102 cases
-
摘要: 目的总结分析土三七所致肝小静脉闭塞病(HVOD)的临床特点,提高对本病的认识。方法对1980年1月至2009年12月国内报道的土三七所致HVOD病例102例进行综合分析,并对国内外相关文献进行复习。结果患者土三七使用量150~5000 g(中位数500 g),服药时间4 d~1年(中位时间30 d),临床主要表现为腹胀(99.0%)、腹痛(69.6%)、肝大(93.5%)、腹水(97.7%)、黄疸(63.5%),有不同程度的肝功能受损。B超检查见肝静脉显示不清,肝段下腔静脉外形变细,但无明显栓塞物,彩色多普勒提示门脉血流减慢或逆向,增强CT示肝脏呈"地图状"强化不均匀。病理学表现为肝窦淤血、扩张,流出道受阻,肝细胞不同程度变性、坏死,小叶中央静脉内皮水肿或纤维增生。经内科治疗好转69.7%(62/89),未愈或死亡30.3%(27/89),另13例转归不详。使用抗凝或活血化瘀者有效率为81.0%,较未用者(47.8%),疗效差异有统计学意义(P=0.002)。结论土三七是导致HVOD的一个重要原因,影像和病理检查具有特征性,早期诊断及使用抗凝、活血治疗对改善预后有一定作用。Abstract: Objective To improve the understanding of the diagnosis and treatment of hepatic veno-occlusive disease (HVOD) by analyzing the clinical features of HVOD caused by gynura root.Methods The clinical data of 102 cases of HVOD caused by gynura root reported from January 1980 to December 2009 in China was analyzed retrospectivelyand the related literatures were reviewed.Results Gynura root was dosed from 150 g to 5000 g (median 500g) , lasted for over 4 days to 1 year (median 30 days) .The main symptoms were abdominal distention (99%) , abdominal pain (69.9%) , hepatomegaly (93.5%) , ascites (97.7%) and jaundice (63.5%) .Liver function may be abnormal.The imaging features were unclear hepatic vein, flat posterohepatic vena cava but no obstruction in it by type-B ultrasonography (US) , slow flow or reflux of portal vein by Doppler US and that contrast agent accumulated unevenly in parenchyma of liver in both portal period and lag period by CT contrast enhancement.The characteristic histological changes included hepatic congestion, sinusoidal dilatation, venous outflow occlusion, hepatocyte necrosis and endothelial oedema or fibrosis of centrilobular vein.After medical treatment, about 69.7% of 89 cases saw improvement, 30.3% of them didn't recover, and other 13 cases were unknown.And there was significant effect in patients who were treated with anticoagulant (81.0%) compared with those without anticoagulant (47.8%) (P=0.002) .Conclusion Gynura root is an important cause of HVOD.Early diagnosis and therapy with anticoagulant may be valuable to improve prognosis.
-
Key words:
- hepatic veno-occlusive disease /
- gynura root
-
[1]侯景贵, 夏玉亭, 余昌时, 等.肝小静脉闭塞病[J].中华内科杂志, 1980, 19 (3) :187-191. [2]曹喆, 李歆彦, 冯向聪, 等.服用中药“土三七”致肝小静脉闭塞症的法医学鉴定[C].中国法医学会法医临床学学术研讨会论文集, 2003:289-290. [3]李志敏, 潘文胜, 蔡建庭, 等.成功治疗土三七致肝小静脉闭塞病一例[J].中华内科杂志, 2005, 44 (2) :144-145. [4]陈卫星, 杨铭, 虞朝晖, 等.土三七致肝小静脉闭塞病2例[J].中华肝脏病杂志, 2005, 13 (5) :394-395. [5]严红, 白岚, 彭梅.菊三七致急性药物性肝损害1例[J].肝脏, 2005, 10 (4) :344. [6]陈毅鹏, 李君, 柴菊爱, 等.肝静脉闭塞病的临床和病理研究[J].中华消化杂, 2006, 26 (4) :224-226. [7]马立新, 陈哉考.土三七致肝静脉闭塞病12例分析[J].临床医学, 2006, 26 (5) :86. [8]李玉香, 杜娜, 王峰, 等.土三七引起急性肝小静脉闭塞症2例报告[J].临床肝胆病杂志, 2006, (4) :319-320. [9]高新生, 肖绍树, 贺降福, 等.土三七致肝小静脉闭塞病1例[J].中国中西医结合消化杂志, 2006, (6) :416-417. [10]吴新军, 张魁, 余孟勇, 等.菊叶三七致肝小静脉闭塞病4例[J].中华肝脏病杂志, 2007, 15 (2) :151-153. [11]Dai N, Yu YC, Ren TH, et al.Gynura root induces hepatic veno-occlusive disease:A case report and review of the literature[J].World J Gastroenterol, 2007, 13 (10) :1628-1631. [12]徐梅梅.肝小静脉闭塞病6例临床分析[J].临床荟萃, 2006, 22 (24) :1781-1782. [13]李尚日, 杨玲, 熊莉娜, 等.肝小静脉闭塞病误诊1例报告并文献复习[J].中西医结合肝病杂志, 2007, (4) :251-252. [14]张智勤, 赵俊彪, 潘锦辉, 等.中西医结合治疗肝小静脉闭塞病17例[J].浙江中医杂志, 2007, 42 (9) :526. [15]刘健红, 濮翔科, 吴云飞.肝内静脉闭塞病的临床与病理诊断[J].实用肝脏病杂志, 2008, 11 (2) :107-109. [16]房龙, 樊艳华, 王晓娣, 等.肝小静脉闭塞病2例并文献复习[J].胃肠病学和肝病学杂志, 2008, (6) :513-516. [17]马新光.肝小静脉闭塞病的彩超表现 (附16例分析) [J].浙江临床医, 2008, 10 (5) :593-594. [18]黄焕军, 刘瑶, 林菊生, 等.土三七致肝小静脉闭塞病诊断及治疗体会[J].临床消化病杂志, 2008, 20 (1) :26-29. [19]王强, 鲁重美, 郭涛.含吡咯烷生物碱的中草药与肝小静脉闭塞病[J].临床消化病杂志, 2008, 20 (1) :22-25. [20]潘锦辉, 中西医结合治疗肝小静脉闭塞病2例[J].江西中医药, 2008, 39 (10) :29-30. [21]梁建丽, 郑小泉, 夏苏娇.2例土三七致肝小静脉闭塞病患者的护理[J].护理学报, 2009, 16 (9) :38-39. [22]李泓, 张顺财, 石虹.土三七致肝小静脉闭塞病2例及文献复习[J].中国临床医学, 2009, 16 (5) :739-741. [23]张满萍, 石红荣, 章玉珍.过量服用菊叶三七致肝小静脉闭塞病的护理体会[J].浙江创伤外科, 2009, 14 (1) :90. [24]黄纪国.土三七致肝小静脉闭塞病8例临床诊治体会[J].现代中西医结合杂志, 2009, 18 (4) :412. [25]郭庆波, 马胜利, 邵凤珍.土三七致肝小静脉闭塞症1例[J].山西中医, 2009, 26 (6) :15. [26]杨丽, 霍继荣, 欧大联.土三七致肝小静脉闭塞症临床与诊断[J].肝脏, 2009, 14 (5) :433-434. [27]Stegelmeier BL, Edgar JA, Colegate SM, et al.Pyrrolizidine alkaloid plants, metabolism and toxicity[J].J Nat Toxins, 1999, 8 (1) :95-116. [28]Srivastava A, Poonkuzhali B, Shaji RV, et al.Glutathione S-transferase M1 polymorphism:a risk factor for hepatic venoocclusive disease in bone marrow transplantation[J].Blood, 2004, 104:1574-1577. [29]Mcdonald GB, Hinds MS, Fisher LD, et al.Veno-occlusive disease of the liver and multiorgan failure after Bone Marrow Transplantation:A cohort study of 355 patients[J].Ann Intern Med, 1993, 118 (4) :255-267. [30]DeLeve LD, Mccuskey RS, Wang X, et al.Characterization of a Reproducible Rat Model of Hepatic Veno-occlusive Disease[J].Hepatology, 1999, 29 (6) :1779-1791. [31]Shulman HM, Gooley T, Dudley MD, et al.Utility of transvenous liver biopsies and wedged hepatic venous pressure measurements in sixty marrow transplant recipients[J].Transplantation, 1995, 59 (7) :1015-1022. [32]Beihany AA, Omar HA, Sahovic E, t al.Successful treatment of hepatic veno-occlusive disease after myeloablative allogeneic hematopoietic stem cell transplantation by early administration of a short course of methylprednisolone[J].Bone Marrow Transplantation, 2008, 41 (3) :287-291. [33]Ho VT, Revta C, Richardson PG.Hepatic veno-occlusive disease after hematopoietic stem cell transplantation:update on defibrotide and other current investigational therapies[J].Bone Marrow Transplantation, 2008, 41 (3) :229-237. [34]李建平, 胡明华, 金慧涵, 等.原位肝移植术治疗肝小静脉闭塞病[J].中华肝胆外科杂志, 2001, 7 (6) :封2. [35]Schlitt HJ, Tischler HJ, Ringe B, et al.Allogeneic liver transplantation for hepatic veno-occlusive disease after bone marrow transplantation clinical and immunological considerations[J].Bone Marrow Transplant, 1995, 16 (3) :473-478.
本文二维码
计量
- 文章访问数: 4386
- HTML全文浏览量: 36
- PDF下载量: 1160
- 被引次数: 0